Swedish Agency for Health Technology Assessment and Assessment of Social Services
Self-Monitoring of Blood Glucose in Noninsulin-Treated Diabetes
Share on Facebook
Share on LinkedIn
Share via Email
SBU does not issue recommendations or guidelines on how healthcare, dental care or social services should operate, or on which interventions and methods should be provided. SBU critically appraises and synthesises research on interventions and methods through systematic reviews.
Conclusions
The scientific evidence does not show any benefits from systematic self-monitoring of blood glucose (SMBG) with test sticks in people with noninsulin-treated type 2 diabetes. Examples of specific situations where people with noninsulin-treated type diabetes may have reason to use test sticks include symptoms of hypoglycemia, particularly in patients being treated with sulfony-lurea agents and meglininides. Self-monitoring may also be needed for other purposes, eg, educational purposes in conjunction with changes in therapy or acute disease.
A more restrictive use of test sticks in the patient group would reduce costs and would not increase medical risks.
How to cite this report: SBU. Self-monitoring of blood glucose in noninsulin-treated diabetes. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009. SBU report no 194 (in Swedish).
